selected publications
- Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate. Nature communications. 2024 Academic Article GET IT
- Canonical AREs are tumor suppressive regulatory elements in the prostate. 2024 GET IT
- Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer. 2023 GET IT
-
Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer.
Cell death & disease.
2023
Academic Article
GET IT
Times cited: 27 -
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer.
Cell death & disease.
2023
Academic Article
GET IT
Times cited: 7 -
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer.
Cell death & disease.
2022
Academic Article
GET IT
Times cited: 5 -
hsa_circ_0092339 acts as a molecular sponge in castration-resistant prostate cancer via the hsa-mir-940/C-MYC axis.
Epigenomics.
2022
Academic Article
GET IT
Times cited: 1 - The cell cycle gene centromere protein K (CENPK) contributes to the malignant progression and prognosis of prostate cancer. Translational cancer research. 2022 Academic Article GET IT
- Downregulation of LOX promotes castration-resistant prostate cancer progression via IGFBP3. Journal of Cancer. 2021 Academic Article GET IT
-
A narrative review of proteolytic targeting chimeras (PROTACs): future perspective for prostate cancer therapy.
Translational andrology and urology.
2021
Review
GET IT
Times cited: 8 -
Increased expression of CELSR3 indicates a poor prognostic factor for Prostate Cancer.
Journal of Cancer.
2021
Academic Article
GET IT
Times cited: 12 -
Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets.
NPJ precision oncology.
2020
Review
GET IT
Times cited: 24 -
YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
Journal of experimental & clinical cancer research : CR.
2020
Academic Article
GET IT
Times cited: 74 -
Restoration of FKBP51 protein promotes the progression of castration resistant prostate cancer.
Annals of translational medicine.
2019
Academic Article
GET IT
Times cited: 339 -
Correction: Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer.
2019
GET IT
Times cited: 1 -
Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer.
Oncogene.
2019
Academic Article
GET IT
Times cited: 31 -
Androgen deprivation therapy with chemotherapy or abiraterone for patients with metastatic hormone-naive prostate cancer: a systematic review and meta-analysis.
Future oncology (London, England).
2019
Review
GET IT
Times cited: 6 -
High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients.
Medical science monitor : international medical journal of experimental and clinical research.
2018
Academic Article
GET IT
Times cited: 15 -
Prognostic signatures for renal cancer as identified by long non-coding and miRNA competing endogenous network analysis.
Oncology reports.
2018
Academic Article
GET IT
Times cited: 4 -
Increased KIF4A expression is a potential prognostic factor in prostate cancer.
Oncology letters.
2018
Academic Article
GET IT
Times cited: 29 -
Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene.
Proceedings of the National Academy of Sciences of the United States of America.
2017
Academic Article
GET IT
Times cited: 23 -
Dual CARS and SHG image acquisition scheme that combines single central fiber and multimode fiber bundle to collect and differentiate backward and forward generated photons.
Biomedical optics express.
2016
Academic Article
GET IT
Times cited: 1 -
Multimodal nonlinear endo-microscopy probe design for high resolution, label-free intraoperative imaging.
Biomedical optics express.
2015
Academic Article
GET IT
Times cited: 20 -
Transformation by Hras(G12V) is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition.
Oncogene.
2013
Academic Article
GET IT
Times cited: 43